Anderson Fávaro da Cunha Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ, 85308, USA The odds of anesthesia‐related mortality are lower in healthy cats and dogs younger than 6 months of age in comparison to adults and older patients [1]; however, their anesthetic management is often considered a clinical challenge [2]. Further, the mortality odds increase in patients with coexisting diseases that can lead to poor functional organ capacity, such as pulmonary, central nervous system (CNS), cardiac, renal, hepatic, and endocrine diseases alone or in combination [3]. Therefore, the relationship between patient life stage and physical status needs to be considered while designing anesthetic protocols. For example, this helps the anesthetist to better understand and appreciate the possible anesthetic challenges associated with each individual and then aids in tailoring the anesthetic management protocol to meet the individual’s need. Accordingly, using the American Animal Hospital Association (AAHA) guidelines, cat [4] and dog [5] life stages are classified; some terms overlap ages (Tables 19.1 and 19.2). It is important to note that defining the terms “neonatal” and “pediatric” is challenging in veterinary medicine. However, in general, the neonatal stage extends from birth to weaning, and the pediatric stage starts after weaning and ends with the beginning of the reproductive maturity [4–6] as described in Table 19.1 [5]. This chapter reviews the physiologic and pharmacologic alterations seen in neonatal and pediatric dogs and cats, as responses clearly change with age [7]. The timing for each developmental stage and the degree of lung development at birth vary significantly among species [8]. For dogs and cats, the initial development of the respiratory system happens well before birth and matures in the postnatal period [8–10]. In comparison to adults, the neonatal and pediatric rib cages are more compliant, intercostal muscles are weaker, work and pressures required to maintain tidal breathing are increased, and respiratory chemoreceptors are immature and less sensitive to increased CO2 and/or decreased O2 (Table 19.3) [10]. Young animals have higher resting respiratory rates and minute volume, increased tendency to develop atelectasis, higher oxygen demand, and lower functional residual capacity (FRC) [10]. Altogether, these changes are possible causes of respiratory fatigue and hypoxemia during anesthesia. Although there is minimal supportive evidence for the exact timing to reach complete adult alveolar development and lung maturity for dogs and cats, the maximum functional efficiency of the dog lungs occurs around 1 year of age [11]. By comparison, in humans, the same level of lung maturity is achieved at the age of 20 [11]. Table 19.1 Canine life stages [5]. Table 19.2 Feline life stages [4]. Because of the abovementioned physiologic alterations, oxygen supplementation prior to anesthesia is recommended for neonatal and pediatric patients. A minimum of 3 min of preinduction oxygenation via face mask, followed by intraoperative and postanesthetic oxygenation (including after extubation), prevents possible hypoxemia [12]. Importantly, a tight‐fitting face mask should be used to efficiently increase the inspiratory fraction of oxygen [13]. For example, in dogs, high flow rates of 100% flow‐by oxygen (without a mask) minimally increased the inspired concentration of oxygen from 21% to 30%, and therefore it is not considered an effective technique [13]. Further, during general anesthesia, intermittent positive pressure ventilation (IPPV) and oxygenation monitoring are recommended via pulse oximetry, capnography, and/or arterial blood gas analysis. Assisted ventilation is often recommended to maintain both normal ventilation (PCO2 between approximately 35 and 45 mmHg) and normal oxygenation (PaO2 higher than approximately 60 mmHg). The neonatal cardiovascular system undergoes dramatic changes immediately after birth to assume its own circulation and maintain homeostasis [14]. The neonatal systemic circulation is often considered a low‐resistance–high‐flow circuit because it is associated with low blood pressure, total blood volume, and peripheral vascular resistance [14–16]. To maintain normal tissue perfusion, the neonatal and pediatric patient must maintain a higher heart rate, cardiac output, plasma volume, and central venous pressure compared to the adult (Table 19.3) [15, 16]. Baroreceptors are not fully mature until approximately 12 weeks of age, leading to decreased vasomotor tone and vasoconstrictive properties; thus, heart rate drives normal cardiac output. To this end, anticholinergics are used frequently during anesthesia to maintain normal to higher heart rates and tissue perfusion. In the newborn, bradycardia is not vagally mediated and is often caused by hypoxemia [15]. Congenital heart defects are common in veterinary medicine. In a veterinary teaching hospital setting, approximately 17% of dogs and 5% of cats examined during a 10‐year period were diagnosed with congenital heart disease. Subaortic stenosis and patent ductus arteriosus in dogs and tricuspid valve dysplasia and ventricular septal defect in cats were among the most common congenital diseases [17]. Specific details of each congenital disease can be found in Chapter 1. Anesthetic‐induced cardiovascular depression and hypotension are common cardiovascular abnormalities observed during procedures; thus, adequate venous return and fluid balance must be maintained to minimize the risk of hypotension [18]. Due to decreased cardiac reserve, fluid overload can lead to congestive heart failure and pulmonary edema. Therefore, fluid rate should be chosen based on the individual need and hydration and physical status. Cardiovascular monitoring is emphasized to detect detrimental changes to the cardiovascular system of young patients that could lead to renal and hepatic insufficiency in adult life. A possible cardiovascular insult during anesthesia while the patient is young could trigger further damage to high perfusion organs that, over time, could lead to possible renal failure during their adult life [19]. Table 19.3 Physiological differences observed in neonatal and pediatric dogs and cats when compared to adults. ↑ = Increase, ↓ = Decrease, CNS = central nervous system. The cytochrome P‐450 enzyme system is immature after birth but develops during postnatal life [20]
19
Neonatal and Pediatric Concerns
Introduction
Physiological Alterations
Respiratory System
Stage
Definition
Neonate
Birth to weaning (approximately 4 weeks of life)
Puppy/pediatric
Weaning until reproductive maturity
Junior
Reproductively mature, yet still growing
Adult
Finished growing, fully mature
Stage
Age
Neonate
Birth to weaning (approximately 4 weeks of life)
Kitten
Birth to 6 months of age
Junior
7 months to 2 years of age
Cardiovascular System
Respiratory system
↑
Rib cage compliance
↓
Intercostal muscle strength
↑
Inspiratory pressure
↑
Work of breathing
↑
Sensitivity to hypercarbia
↓
Sensitivity to hypoxemia
↑
Resting respiratory rate
↑
Minute volume
↑
Tendency to develop atelectasis
↑
Oxygen demand
↓
Functional residual capacity
Cardiovascular system
↓
Blood pressure
↑
Heart rate
↑
Cardiac output
↓
Systemic vascular resistance
↓
Ability to vasoconstrict
↓
Baroreceptor maturity
↓
Central venous pressure
↑
Plasma volume
↓
Blood volume
Hepatic system
↓
Cytochrome P‐450 enzyme system maturity
↓
Albumin levels
↓
Drug metabolism
↓
Gluconeogenic ability
Central nervous system
↓
CNS maturity
↓
Neuromuscular junction maturity
↓
Thermoregulatory center responsiveness
↑
Susceptibility to hypothermia
Renal system
↓
Nephrogenesis
↓
Clearance rate
↓
Glomerular filtration rate
↓
Renal plasma flow
↓
Concentrating ability
↓
Filtration fraction
↓
Amino acids and phosphate reabsorption
↑
Proximal tubule natriuresis
↑
Phosphorous concentrations
↓
Creatinine concentrations
↓
Blood urea nitrogen concentrations
Pharmacokinetics
↑
Drug elimination time
↓
Albumin–drug affinity
↓
Protein‐bound
↑
Blood–brain barrier permeability
↑
Body water content
↓
Fat content
↑
Initial volume of distribution for water‐soluble drugs
↓
Smaller volume of distribution for lipid‐soluble drugs
Hepatic System
Stay updated, free articles. Join our Telegram channel